The Discounted Cash Flow (DCF) valuation of Enanta Pharmaceuticals Inc (ENTA) is (104.31) USD. With the latest stock price at 5.58 USD, the upside of Enanta Pharmaceuticals Inc based on DCF is -1969.3%.
Based on the latest price of 5.58 USD and our DCF valuation, Enanta Pharmaceuticals Inc (ENTA) is a sell. selling ENTA stocks now will result in a potential gain of 1969.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 10.8% | 8.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (345.21) - (62.47) | (104.31) |
| Upside | -6286.5% - -1219.6% | -1969.3% |